Clinical Trial Update: Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing intra-erythrocyte dexamethasone to placebo in steroid-dependent Crohn's disease was terminated, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Intra-erythrocyte Dexamethasone (dexamethasone)

Snippet

Sponsor: Quince Therapeutics S.p.A. | Conditions: Crohn's Disease | Phase 3 | Status: TERMINATED | Results posted: 2024-06-03